West Pharmaceutical Services Inc(WST) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 4:05 PM ET (Korea 10/31 05:05)
Full metrics table
| Index | S&P 500 | P/E | 46.27 | EPS (ttm) | 8.92 | Insider Own | 0.75% | Shs Outstand | 70.4M | Perf Week | 5.22% |
| Market Cap | 29.04B | Forward P/E | 40.28 | EPS next Y | 8.9% | Insider Trans | -2.88% | Shs Float | 69.8M | Perf Month | 13.04% |
| Enterprise Value | 28.89B | PEG | 2.33 | EPS next Q | 2.29 | Inst Own | 103.06% | Short Float | 2.88% | Perf Quarter | 18.59% |
| Income | 0.64B | P/S | 8.55 | EPS this Y | 29.02% | Inst Trans | -2.04% | Short Ratio | 3.52 | Perf Half Y | 37.23% |
| Sales | 3.40B | P/B | 9.7 | EPS next 5Y | 17.31% | ROA | 15.65% | Short Interest | 2.01M | Perf YTD | 49.97% |
| Book/sh | 42.52 | P/C | 62.57 | EPS past 3/5Y | -4.22% 8.26% | ROE | 21.23% | 52W High | -5.85% ($438.27) | Perf Year | 48.14% |
| Cash/sh | 6.59 | P/FCF | 64.05 | Sales past 3/5Y | 2.14% 7.45% | ROIC | 19.59% | 52W Low | 84.35% ($223.83) | Perf 3Y | 29% |
| Dividend Est. | $0.88 (0.21%) | EV/EBITDA | 30 | EPS Y/Y TTM | 17.07% | Gross Margin | 37.68% | Volatility(W/M) | 2.47% 2.36% | Perf 5Y | -4.02% |
| Dividend TTM | 0.88 | EV/Sales | 8.5 | Sales Y/Y TTM | 12.6% | Oper. Margin | 22.92% | ATR (14) | 10.31 | Perf 10Y | 462.92% |
| Dividend Ex-Date | 2026/11/10 | Quick Ratio | 2.1 | EPS Q/Q | 56.74% | Profit Margin | 18.81% | RSI (14) | 75.33 | Recom | 1.37 |
| Dividend Gr. 3/5Y | 5.14% 5.44% | Current Ratio | 2.82 | Sales Q/Q | 8.72% | SMA20 | 7.11% ($385.23) | Beta | 1.15 | Target Price | $470 |
| Payout | 12.66% | Debt/Eq | 0.11 | Earnings | 2026/10/29 | SMA50 | 12.25% ($367.59) | Rel Volume | 1.86 | Prev Close | $416.67 |
| Employees | 10800 | LT Debt/Eq | 0.1 | EPS/Sales Surpr. | 20.87% 5.73% | SMA200 | 31.67% ($313.37) | Avg Volume(3M) | 0.57M | Price | $412.62 |
| IPO | 1980/3/17 | Option/Short | Yes/Yes | Trades | 19519 | Volume | 1,062,306 | Change | -0.97% |
🧪 West Pharmaceutical Services (WST) is a global leader in the packaging and delivery systems market for injectable pharmaceuticals. The company manufactures and supplies packaging solutions—such as high-performance elastomer stoppers, vial seals, and self-injection systems—that help ensure the stable storage and administration of high-value medications.
Over the past 1 year, on the higher side
6% below its 1-year high.
Traded more than usual. That is 186% of its average volume.
Ex-dividend date: November 10
11 days to go. Buy before this date to receive the dividend.
WST makes money exceptionally well
Of every $100 in sales, $22.92 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +29.0% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $4,028. Peers typically go for $1,901. Compared with its own 5-year average, it is 24% pricier now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 5 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -4.0%. The S&P 500 did +65% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.21% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 103.1%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #6 of 51 in the industry
Based on market cap of $29B.
BDX#2 Becton Dickinson & Co $54B PER 59.7 
MDLN#3 Medline Inc $42B PER 37.6 
ALC#4 Alcon Inc $34B PER 54.8 
RMD#5 Resmed Inc $32B PER 20.9 
WST#6 West Pharmaceutical Services Inc $29B PER 46.3 
FAQ
What kind of company is WST?
WST belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of WST?
The market cap of WST is approximately $29.0B, ranking 474 within its sector.
Does WST pay dividends?
WST has a dividend yield of approximately 0.21%, with an annual dividend of $0.88.
What is the P/E ratio of WST?
WST has a P/E ratio of approximately 46.3x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for WST?
WST has recorded a 52-week high of $438.27 and a low of $223.83.
